The capital gap in cancer innovation is solvable.
As oncologists, we feel the need to improve outcomes and see how innovations might help patients and providers like us.
CANCER FUND helps provide the capital needed to advance those diagnostic, therapeutic and supportive care innovations into the clinic faster and improve the patient journey.
As a Venture Partner at CANCER FUND, I help identify, evaluate, and support the companies we invest in. As a community member or Screening Committee Member, you can too.
What We’ve Built
A fund supported by input from experts, patients, and a community that wants to make a difference in cancer therapies, diagnostics, enabling technologies, and digital health.
Communication is part of the solution.
Bring your perspective to the work
Our Screening Committee evaluates cancer innovations coming through our pipeline. Oncologists on the committee bring the clinical perspective that helps inform which companies we support.
Complete the short form below and we’ll email you a sample Quick-Look to review. Finishing it — which includes agreeing to our confidentiality agreement — is the final step, and admits you to the Screening Committee.
"*" indicates required fields
Participation in the Screening Committee, and any use of this site, is subject to our privacy policy and terms of service.
How we support cancer innovation
The funding for our investments doesn’t come from Wall Street, Big Pharma, or large investment firms.
It comes from patients, survivors, and the people who care about them and for them, including oncologists like me and possibly you.
Cancer Fund I, LLC offers its investments under Rule 506(c) issued by the Securities and Exchange Commission. Investments are offered only to accredited investors who can bear the economic risk of their investment for an indefinite period and can afford to sustain a total loss of their investment. No investor funds will be accepted absent execution and delivery of final definitive legal agreements. This page does not constitute an offer to sell or purchase securities. Not available to residents of California, New York, Illinois, or Massachusetts.
Donor-advised fund (DAF) grants are made through ImpactAssets, Inc., a 501(c)(3) public charity (EIN 26-2048480), which retains full legal discretion over and is the legal investor of record for CFC-DAF investments. Contributions are irrevocable and tax-deductible to the extent permitted by law. Nothing on this page constitutes an offer to sell or a solicitation to purchase securities.
CANCER FUND does not promise or guarantee cures, clinical outcomes, or investment returns. This page describes what we do and why we do it.
CANCER FUND Impact Investments® is a registered trademark of CXO Advisors & Management, LLC d/b/a CANCER FUND. 3200 East Camelback Road, Suite 130, Phoenix, AZ 85018. © 2020–2026. All rights reserved.